NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

Next predicted deadline: Jan 15, 2024 (Letter of inquiry)

Later predicted deadlines: Feb 15, 2024 (Full proposal)

Grant amount: Up to US $225,000

Funding uses: Research

Location of project: Anywhere in the world

Location of residency: United States, American Samoa, Guam, Northern Mariana Islands, Puerto Rico, Virgin Islands Show all

Overview:

NOTE: All applications are due by 5:00 PM local time of applicant organization.  Consultation with NIDDK scientific staff is strongly encouraged prior to the submission of the U34 application.

NIDDK supports investigator-initiated, high-risk multi-center (more than one center) clinical studies through a two-part process that may include an implementation planning cooperative agreement (U34). The U34 is designed to:

• Permit early peer review of the rationale for the proposed clinical study; 
• Permit assessment of the design and protocol of the proposed study;
• Provide support for the development of documents needed for the conduct of the study, including a manual of operations; and
• Support the development of other essential elements required for the conduct of the clinical study. The proposed clinical study should be hypothesis-driven and focus on a disease in the mission of NIDDK.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.